Abstract
In animal and human studies glucagon-like peptide-2 (GLP-2) has been shown to increase blood flow in the superior mesenteric artery and the portal vein. This study describes the effect of GLP-2 measured directly on the intestinal mucosal blood flow by laser Doppler flowmetry (LDF) in end-jejunostomy short bowel syndrome (SBS) patients.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Regulatory Peptides |
| Vol/bind | 180 |
| Sider (fra-til) | 12-6 |
| Antal sider | 5 |
| ISSN | 0167-0115 |
| DOI | |
| Status | Udgivet - 10 jan. 2013 |
Fingeraftryk
Dyk ned i forskningsemnerne om 'Glucagon-like peptide-2 stimulates mucosal microcirculation measured by laser Doppler flowmetry in end-jejunostomy short bowel syndrome patients'. Sammen danner de et unikt fingeraftryk.Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS